AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Fangfang Gao
Public Documents
1
July 28, 2025
Long-term survival benefit from first-line immunotherapy followed by BRAF/MEK inhibit...
Fangfang Gao, Zhongkang Li, Huanhuan Wang, et al.
